These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27777041)

  • 21. Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor.
    Lehrer S
    Med Hypotheses; 2012 May; 78(5):657-8. PubMed ID: 22385772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.
    Wakefield A; Pignata A; Ghazi A; Ashoori A; Hegde M; Landi D; Gray T; Scheurer ME; Chintagumpala M; Adesina A; Gottschalk S; Hicks J; Powell SZ; Ahmed N
    J Neurooncol; 2015 Nov; 125(2):307-15. PubMed ID: 26341370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations.
    Price RL; Song J; Bingmer K; Kim TH; Yi JY; Nowicki MO; Mo X; Hollon T; Murnan E; Alvarez-Breckenridge C; Fernandez S; Kaur B; Rivera A; Oglesbee M; Cook C; Chiocca EA; Kwon CH
    Cancer Res; 2013 Jun; 73(11):3441-50. PubMed ID: 23729642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegaloviruses and malignant brain tumors.
    Lisyany NI; Klyuchnikova AA; Belskaya LN; Lisyany AA; Gnedkova IA
    Exp Oncol; 2019 Dec; 41(4):300-303. PubMed ID: 31868329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of cytomegalovirus in glioblastoma multiforme: Myth or reality?
    Taha MS; Abdalhamid BA; El-Badawy SA; Sorour YM; Almsned FM; Al-Abbadi MA
    Br J Neurosurg; 2016 Jun; 30(3):307-12. PubMed ID: 26742571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term glioblastoma survival following recovery from cytomegalovirus colitis: A case report.
    Lamano JB; Quaggin-Smith JA; Horbinski CM; Tate MC; Grimm SA; Kumthekar PU; Bloch O
    J Clin Neurosci; 2019 Jun; 64():18-21. PubMed ID: 30948314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression.
    Cinatl J; Vogel JU; Kotchetkov R; Wilhelm Doerr H
    FEMS Microbiol Rev; 2004 Feb; 28(1):59-77. PubMed ID: 14975530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation.
    Cinatl J; Scholz M; Doerr HW
    Med Res Rev; 2005 Mar; 25(2):167-85. PubMed ID: 15389728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in glioblastoma oncosuppressive pathways pave the way for oncomodulatory activity of cytomegalovirus.
    Hollon TC; Price RL; Kwon CH; Chiocca EA
    Oncoimmunology; 2013 Sep; 2(9):e25620. PubMed ID: 24319635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Neurotropic Viruses in Malignant Glioma and Their Onco-Modulatory Potential.
    Strojnik T; Duh D; Lah TT
    In Vivo; 2017; 31(2):221-229. PubMed ID: 28358704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review: CMV escapes!
    Froberg MK
    Ann Clin Lab Sci; 2004; 34(2):123-30. PubMed ID: 15228222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus infection of glioblastoma cells leads to NF-κB dependent upregulation of the c-MET oncogenic tyrosine kinase.
    Krenzlin H; Zdioruk M; Nowicki MO; Finkelberg T; Keric N; Lemmermann N; Skubal M; Chiocca EA; Cook CH; Lawler SE
    Cancer Lett; 2021 Aug; 513():26-35. PubMed ID: 33989707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of HCMV infection on p38MAPK of human gliomatous cell U251 strain].
    Li TC; Chen LY; Dai G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):486-8. PubMed ID: 16134615
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence based on a meta-analysis of human cytomegalovirus infection in glioma.
    Farias KPRA; Moreli ML; Floriano VG; da Costa VG
    Arch Virol; 2019 May; 164(5):1249-1257. PubMed ID: 30888562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sepsis and cytomegalovirus: foes or conspirators?
    Mansfield S; Grießl M; Gutknecht M; Cook CH
    Med Microbiol Immunol; 2015 Jun; 204(3):431-7. PubMed ID: 25788396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus and glioblastoma; controversies and opportunities.
    Lawler SE
    J Neurooncol; 2015 Jul; 123(3):465-71. PubMed ID: 25682092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human cytomegalovirus infection in Iranian glioma patients correlates with aging and tumor aggressiveness.
    Maleki F; Sadigh ZA; Sadeghi F; Muhammadnejad A; Farahmand M; Parvin M; Shirkoohi R
    J Med Virol; 2020 Aug; 92(8):1266-1276. PubMed ID: 31944314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of CMV viremia in high-grade glioma patients under low dosage glucocorticoid treatment.
    Schneider M; Reitter EM; Kastner MT; Thannesberger J; Rieder FJJ; Preusser M; Marosi C; Steininger C
    Neuro Oncol; 2017 Sep; 19(9):1280-1282. PubMed ID: 28821204
    [No Abstract]   [Full Text] [Related]  

  • 39. Is cytomegalovirus a therapeutic target in glioblastoma?
    Sampson JH; Mitchell DA
    Clin Cancer Res; 2011 Jul; 17(14):4619-21. PubMed ID: 21632859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
    Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
    World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.